The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients

Europace

Volumn 13, Issue 7, 2011, Pages 1034-1039

  Probst, Vincent ^a   Plassard Kerdoncuf, Delphine ^a   Mansourati, Jacques ^b   Mabo, Philippe ^c   Sacher, Frédéric ^d   Fruchet, Christine ^a   Babuty, Dominique ^e   Lande, Gilles ^a   Guyomarc'H, Béatrice ^a   Le Marec, Hervé ^a  

^a L INSTITUT DU THORAX   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e SERVICE DE DERMATOLOGIE   (France)

Author keywords

Brugada syndrome; Complications; Implantable cardioverter defibrillator; Quality of life; Socio professional

Indexed keywords

ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CAREER; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOANALYSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36;

ADULT; AGED; BRUGADA SYNDROME; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FRANCE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 79959734728     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur060     Document Type: Article

References (26)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
2. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005;2:429-40. (Pubitemid 40439292)
3. Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation 2009;120:278-85.
4. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004;110:1731-7. (Pubitemid 39299213)
5. Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm 2009;6:401-4.
6. Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004;43:1853-60. (Pubitemid 38622526)
7. Brugada P, Brugada R, Mont L, Rivero M, Geelen P, Brugada J. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol 2003;14:455-7. (Pubitemid 36583902)
8. Priori SG, Napolitano C, Gasparini M, Pappone C, Bella PD, Giordano U et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-7. (Pubitemid 34260426)
9. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257-63. (Pubitemid 40165330)
10. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006;114:2317-24. (Pubitemid 44847448)
11. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation 2010;121:635-43.
12. Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S et al. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J 2008;10:435-9.
13. Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T et al. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J 2007;28:334-44.
14. Sears SF Jr, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 1999;22:481-9. (Pubitemid 29302759)
15. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002;87:488-93. (Pubitemid 34454597)
16. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 2009;149A:602-12.
17. Smets EM, Stam MM, Meulenkamp TM, van Langen IM, Wilde AA, Wiegman A et al. Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am J Med Genet A 2008;146A:700-7. (Pubitemid 351354145)
18. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306:1440-4.
19. Gresset J, Boisjoly H, Nguyen TQ, Boutin J, Charest M. Validation of French-language versions of the Visual Functioning Index (VF-14) and the cataract symptom score. Can J Ophthalmol 1997;32:31-7. (Pubitemid 27117607)
20. Perneger TV, Leplege A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-item short form health survey (SF-36) in young healthy adults. J Clin Epidemiol 1995;48:1051-60.
21. Groeneveld PW, Matta MA, Suh JJ, Yang F, Shea JA. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era. Pacing Clin Electrophysiol 2007;30:463-71. (Pubitemid 46596121)
22. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105:589-94. (Pubitemid 34123433)
23. Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007;167:2226-32. (Pubitemid 350106743)
24. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008;359:999-1008.
25. Pedersen SS, den Broek KC, Theuns DA, Erdman RA, Alings M, Meijer A et al. Risk of chronic anxiety in implantable defibrillator patients: a multi-center study. Int J Cardiol. 2011;147:420-423.
26. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111:2898-905. (Pubitemid 40814182)